DXCM vs SPRB · P/E 63, rev $2.50B vs $3.0M cap
DexCom Inc (DXCM) versus Spruce Biosciences Inc (SPRB) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Spruce Biosciences Inc (SPRB) is a biotechnology company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported SPRB revenue for 2025-09-30 was $0. Net income was -$24.3M. SPRB currently screens at market cap $3.0M.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. SPRB currently screens at market cap $3.0M.
Not investment advice. Open the DXCM and SPRB stock pages for the full models.
Not investment advice.